Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

APPOINTMENTS: Apellis, Araim, Ascendis, Chronos, Intrexon and Proteostasis

Executive Summary

Chrono Therapeutics Inc. has hired two ex-Shire PLC executives to lead clinical development for the recently acquired pipeline programs it picked up from the Irish pharma company. Meanwhile, Apellis Pharmaceuticals Inc., Ascendis Pharma A/S, Intrexon Corporation and Proteostasis Therapeutics Inc. have made senior appointments and Araim Pharmaceuticals has named a new chair for its board of directors.

Advertisement

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC097118

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel